In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database

© 2021 Future Medicine Ltd..

Aim: SARS-CoV-2 caused more than 3.8 million deaths according to the WHO. In this urgent circumstance, we aimed at screening out potential inhibitors targeting the main protease of SARS-CoV-2. Materials & methods: An in-house carboline and quinoline database including carboline, quinoline and their derivatives was established. A virtual screening in carboline and quinoline database, 50 ns molecular dynamics simulations and molecular mechanics Poisson-Boltzmann surface area calculations were carried out. Results: The top 12 molecules were screened out preliminarily. The molecular mechanics Poisson-Boltzmann surface area ranking showed that p59_7m, p12_7e, p59_7k stood out with the lowest binding energies of -24.20, -17.98, -17.67 kcal/mol, respectively. Conclusion: The study provides powerful in silico results that indicate the selected molecules are valuable for further evaluation as SARS-CoV-2 main protease inhibitors.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - year:2021

Enthalten in:

Future virology - (2021) vom: 01. Juli

Sprache:

Englisch

Beteiligte Personen:

Muhtar, Eldar [VerfasserIn]
Wang, Mengyang [VerfasserIn]
Zhu, Haimei [VerfasserIn]

Links:

Volltext

Themen:

Carboline
DPCA
Journal Article
MD simulation
MM-PBSA
Main protease
SARS-CoV-2
Virtual screening

Anmerkungen:

Date Revised 27.07.2021

published: Print-Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.2217/fvl-2021-0099

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM328509876